Cellular and tissue distribution of intravenously administered agalsidase alfa (Q35728693)

9 August 2017

Cellular and tissue distribution of intravenously administered agalsidase alfa (English)

1 reference

9 August 2017

Gary J Murray

1

1 reference

9 August 2017

Miriam R Anver

2

1 reference

9 August 2017

Maureen A Kennedy

3

1 reference

9 August 2017

Jane M Quirk

4

1 reference

9 August 2017

Raphael Schiffmann

5

1 reference

9 August 2017

22 December 2006

1 reference

Molecular Genetics and Metabolism

9 August 2017

1 reference

9 August 2017

90

1 reference

9 August 2017

307-312

1 reference

9 August 2017

3

1 reference

Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease.

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

12 July 2018

Pediatric Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Enzyme replacement therapy in Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Clinical features of and recent advances in therapy for Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

alpha-Galactosidase A deficient mice: a model of Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Endothelial fenestral diaphragms: a quick-freeze, deep-etch study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Distribution of insulin-like growth factor II receptor immunoreactivity in rat tissues

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Comparison of receptors for insulin-like growth factor II from various rat tissues.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Purification and properties of the two major isozymes of alpha-galactosidase from human placenta

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Fabry's disease--an important risk factor for stroke.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1839873

Enzymatic Defect in Fabry's Disease

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

Identification and characterization of insulin-like growth factor I (IGF-I) and IGF-II/mannose-6-phosphate (IGF-II/M6P) receptors in bovine adrenal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

Ultrastructure of the secretory epithelium, nerve fibers, and capillaries in the mouse sweat gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

The kinetics and tissue distribution of protein transduction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.11.008

10.1016/J.YMGME.2006.11.008

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference